Publicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (40)

2024

  1. BRIVA-ONE study: 12-month outcomes of brivaracetam monotherapy in clinical practice

    Epilepsia Open

2023

  1. Exploring the Spectrum of RHOBTB2 Variants Associated with Developmental Encephalopathy 64: A Case Series and Literature Review

    Movement Disorders Clinical Practice, Vol. 10, Núm. 11, pp. 1671-1679

  2. La señal de la cruz: un automatismo muy poco frecuente en la epilepsia del lóbulo temporal. Descripción de dos casos

    Revista de neurologia, Vol. 77, Núm. 4, pp. 105-108

  3. Real-world safety and effectiveness of cenobamate in patients with focal onset seizures: Outcomes from an Expanded Access Program

    Epilepsia Open, Vol. 8, Núm. 3, pp. 918-929

  4. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA)

    Epilepsy and Behavior, Vol. 145

2022

  1. Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy

    Epilepsy and Behavior, Vol. 137

2021

  1. New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol

    Revista de Neurologia, Vol. 72, pp. S1-S10

  2. Perampanel effectiveness and safety as early add-on treatment for focal-onset seizures: PEREAGAL study

    Epilepsy Research, Vol. 172

2020

  1. Consensus statement for the management of generalized tonic-clonic seizures in Spain

    Acta Neurologica Scandinavica, Vol. 141, Núm. 1, pp. 22-32

  2. Intensity normalization methods in brain FDG-PET quantification

    NeuroImage, Vol. 222

  3. Observational multicentre study into the use of antiepileptic drugs in Spanish neurology consultations

    Neurologia, Vol. 35, Núm. 2, pp. 115-125

2019

  1. BRIVA-LIFE–A multicenter retrospective study of the long-term use of brivaracetam in clinical practice

    Acta Neurologica Scandinavica, Vol. 139, Núm. 4, pp. 360-368

  2. Clinical outcomes of eslicarbazepine acetate monotherapy for focal-onset seizures: A multicenter audit

    Acta Neurologica Scandinavica, Vol. 140, Núm. 6, pp. 422-428

  3. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy

    Epilepsy and Behavior, Vol. 97, pp. 51-59

2018

  1. Functional hemispherectomy: Long-term follow-up in a series of five patients

    Revista de Neurologia, Vol. 66, Núm. 5, pp. 147-153

  2. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting

    Epilepsy Research, Vol. 145, pp. 51-54

  3. Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data

    Epilepsia, Vol. 59, Núm. 9, pp. 1727-1739

  4. Perampanel in routine clinical use in idiopathic generalized epilepsy: The 12-month GENERAL study

    Epilepsia, Vol. 59, Núm. 9, pp. 1740-1752

  5. Retrospective study of perampanel efficacy and tolerability in myoclonic seizures

    Acta Neurologica Scandinavica, Vol. 138, Núm. 2, pp. 122-129

2017

  1. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

    Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264